"Last year, I nearly died after a severe asthma attack and I'm worried that it will happen all over again and I can't afford my Prescription Prepayment Certificate at the moment"
New research published in May 2018 by the York Health Economics Consortium (YHEC) has found that scrapping prescription charges for people with two long-term conditions - Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis) and Parkinson’s - would save the NHS over £20 million a year.
Download a summary of key findings taken from the 2018 report by the York Health Economics Consortium on the economic benefit of scrapping prescription charges for people with Parkinson's and Inflammatory Bowel Disease.
In June 2017, the Prescription Charges Coalition launched its Still Paying the Price report, highlighting the ongoing detrimental impact that prescription charges are having on the health and wellbeing of people with long-term conditions.
In 2015 the Prescription Charges Coalition successfully campaigned with other charities to stop the reintroduction of prescription charges in Northern Ireland. The Keep Us Well report, which uses data provided by the Prescription Charges Coalition, was produced as part of that campaign.
In March 2014, the Prescription Charges Coalition launched its second report into prescription charges and employment. The report examines the impact of prescription charges on the working lives of people with long-term conditions in England.
In March 2013, the Prescription Charges Coalition launched its Paying the Price report, highlighting the significant, detrimental impact that prescription charges are having on people with long-term conditions.
The Prescription Charges Coalition is co-chaired by Parkinson's UK, Crohn's and Colitis UK and National Rheumatoid Arthritis Society.